Biomarkers in Medicine, Год журнала: 2025, Номер unknown, С. 1 - 12

Опубликована: Фев. 24, 2025

Over the past few years, circulating cell-free DNA (cfDNA) research has grown exponentially. Several studies have associated release of cfDNA in bloodstream, cerebrospinal fluid, and other body fluids with increased apoptosis cell death. Therefore, their possible use as biomarkers for cancer diseases emerged. The diagnosis pathological entities such schizophrenia neurodegenerative involves many challenges requires ruling out conditions similar symptoms. In this context, could serve a valuable diagnostic biomarker. This study encompasses recent bibliography regarding utilization purposes schizophrenia, Alzheimer's disease, Parkinson's multiple sclerosis, amyotrophic lateral Huntington's disease. minimally invasive method provided important evidence aforementioned although further is necessary.

Язык: Английский